<main role="main" class="html-publication" lang="en">
      

  <div class="publication-external">
    <ul class="organisation-logos">
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color" href="/government/organisations/department-of-health-and-social-care">
      <span class="gem-c-organisation-logo__name">Department<br>of Health &amp;<br>Social Care</span>
</a>
</div>
        </li>
        <li class="organisation-logos__logo">
          
<div class="gem-c-organisation-logo brand--department-of-health">
    <a href="/government/organisations/uk-health-security-agency" class="gem-c-organisation-logo__container gem-c-organisation-logo__link gem-c-organisation-logo__crest gem-c-organisation-logo__crest--single-identity brand__border-color">
      <span class="gem-c-organisation-logo__name">UK Health<br>Security<br>Agency</span>
</a>
</div>
        </li>
    </ul>
  </div>

  <header class="gem-c-inverse-header  gem-c-inverse-header--padding-top ">
    
  

<div class="gem-c-title gem-c-title--inverse govuk-!-margin-top-8 govuk-!-margin-bottom-0">
      <span class="govuk-caption-xl gem-c-title__context">
    Guidance
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-xl">
    Products in the pipeline (TVG): validation concluded or paused
  </h1>
</div>
  <p class="publication-header__last-changed">Updated 20 January 2022</p>

  </header>



<div class="govuk-grid-row sidebar-with-body" data-module="sticky-element-container">

  <div class="print-wrapper">
    <div class="print-meta-data">
      <p>
  <img class="print-meta-data-licence" src="/assets/government-frontend/open-government-licence-min-e98134ae65ff5fe99a524d8c383350b3998f91c298dc24b36126e65f1656c578.png">
</p>
<p>
  © Crown copyright 2022
</p>
<p>
  This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit <a href="https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3">nationalarchives.gov.uk/doc/open-government-licence/version/3</a> or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: <a href="mailto:psi@nationalarchives.gov.uk">psi@nationalarchives.gov.uk</a>.
</p>
<p>
  Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
</p>
<p>
  This publication is available at https://www.gov.uk/government/publications/assessment-and-procurement-of-coronavirus-covid-19-tests/products-in-the-pipeline-tvg-validation-concluded-or-paused
</p>


    </div>
  </div>

  <div class="main-content-container offset-empty-contents-list">
    <div class="gem-c-govspeak-html-publication">
  
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak ">
    
    
      <div class="govspeak">
<p>The Technical Validation Group (TVG) have concluded or paused the validation of the following products.</p>

<table>
  <thead>
    <tr>
      <th scope="col">TVG reference</th>
      <th scope="col">Primary use location</th>
      <th scope="col">Product type</th>
      <th scope="col">High-level justification</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>4</td>
      <td>Near patient test</td>
      <td>Bespoke</td>
      <td>Multiplex assay and validation sits outside   of <abbr title="Department of Health and Social Care">DHSC</abbr> (to be performed locally)</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Rejected for commercial reasons following the   commencement of validation activities</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Near patient test</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Near patient test or point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product withdrawn from validation by the supplier</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Near patient test or point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product withdrawn from validation by the supplier</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product currently research only, with significant   transportation constraints</td>
    </tr>
    <tr>
      <td>18</td>
      <td>Point of care test</td>
      <td>Direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Assay does not meet <abbr title="target product profile">TPP</abbr> standards for   sensitivity. Biosafety concerns also noted</td>
    </tr>
    <tr>
      <td>20</td>
      <td>Near patient test</td>
      <td>Direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Scalability, manufacturing and biosafety concerns</td>
    </tr>
    <tr>
      <td>21</td>
      <td>Near patient test</td>
      <td>
<abbr title="ribonucleic acid">RNA</abbr> and direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Product not market ready – reliability issues and   does not meet <abbr title="target product profile">TPP</abbr> standards</td>
    </tr>
    <tr>
      <td>22</td>
      <td>Near patient test</td>
      <td>Direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Protocol being updated by the company to improve   clinical performance</td>
    </tr>
    <tr>
      <td>23</td>
      <td>Point of care test</td>
      <td>Antigen</td>
      <td>Assay does not provide additional capacity to meet   <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>24</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative route</td>
    </tr>
    <tr>
      <td>25</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product withdrawn from validation by the supplier</td>
    </tr>
    <tr>
      <td>27</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Product already being supplied by another   distributor</td>
    </tr>
    <tr>
      <td>28</td>
      <td>Laboratory</td>
      <td>
<abbr title="ribonucleic acid">RNA</abbr> and direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Resilience and scalability concerns</td>
    </tr>
    <tr>
      <td>29</td>
      <td>Point of care test</td>
      <td>Microelectronics and microfluidics</td>
      <td>Product is not ready for market – very early stages   of development</td>
    </tr>
    <tr>
      <td>30</td>
      <td>Point of care test</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>31</td>
      <td>Laboratory</td>
      <td>
<abbr title="ribonucleic acid">RNA</abbr> <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Product is not ready for market – very early stages   of development</td>
    </tr>
    <tr>
      <td>33</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative route</td>
    </tr>
    <tr>
      <td>34</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>35</td>
      <td>Laboratory</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Rejected due to little differentiation between   negative reaction and presumes positive result, and low throughput</td>
    </tr>
    <tr>
      <td>36</td>
      <td>Laboratory; near patient test</td>
      <td>Other</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>37</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative route</td>
    </tr>
    <tr>
      <td>38</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>42</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>43</td>
      <td>Laboratory</td>
      <td>Mass spectrometry</td>
      <td>Validated as a part of a broader pilot (different   validation route)</td>
    </tr>
    <tr>
      <td>44</td>
      <td>Point of care test</td>
      <td><abbr title="point of care test">POCT</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>45</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>46</td>
      <td>Point of care test</td>
      <td>Direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>47</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>49</td>
      <td>Point of care test; near patient test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Multiplex assay and validation sits outside of <abbr title="Department of Health and Social Care">DHSC</abbr>   (to be performed locally)</td>
    </tr>
    <tr>
      <td>50</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>51</td>
      <td>Laboratory</td>
      <td>Digital sequencing test</td>
      <td>Product not market ready – does not   meet <abbr title="target product profile">TPP</abbr> standards and has reliability issues</td>
    </tr>
    <tr>
      <td>53</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>54</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>55</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier withdrew product</td>
    </tr>
    <tr>
      <td>56</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>58</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>60</td>
      <td>Near patient test or point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>62</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>63</td>
      <td><abbr title="point of care test">POCT</abbr></td>
      <td>&nbsp;</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>64</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>65</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Solution not viable within the timelines required   to support with <abbr title="Department of Health and Social Care">DHSC</abbr> surge capacity</td>
    </tr>
    <tr>
      <td>66</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>67</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>68</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>70</td>
      <td>Point of care test</td>
      <td>Direct <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Product is not ready for market – very early stages   of development</td>
    </tr>
    <tr>
      <td>72</td>
      <td>Point of care test</td>
      <td>
<abbr title="ribonucleic acid">RNA</abbr> <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Did not meet <abbr title="target product profile">TPP</abbr> Standards on   sensitivity, concerns of throughput</td>
    </tr>
    <tr>
      <td>73</td>
      <td>Laboratory</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>74</td>
      <td>Near patient test</td>
      <td>Antibody</td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>75</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>76</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier withdrew product</td>
    </tr>
    <tr>
      <td>78</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>80</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>82</td>
      <td>Laboratory</td>
      <td>
<abbr title="ribonucleic acid">RNA</abbr> <abbr title="loop-mediated isothermal amplification">LAMP</abbr>
</td>
      <td>Use cases restricted and not adding any additional   testing capacity</td>
    </tr>
    <tr>
      <td>85</td>
      <td>Laboratory</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Limited use case due to clinical performance and   assay being laboratory</td>
    </tr>
    <tr>
      <td>86</td>
      <td>Laboratory</td>
      <td>RT <abbr title="polymerase chain reaction">PCR</abbr>
</td>
      <td>End-to-end solution and validation routed to an   alternative team</td>
    </tr>
    <tr>
      <td>87</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>89</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>92</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>93</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>95</td>
      <td>Point of care test</td>
      <td>Antigen</td>
      <td>Validation paused to clarify assay performance. In   addition, contradictory statements in the <abbr title="instructions for use">IFU</abbr> on the assay</td>
    </tr>
    <tr>
      <td>96</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>97</td>
      <td>Laboratory</td>
      <td>Lateral flow</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>98</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Multiplex assay and validation sits outside   of <abbr title="Department of Health and Social Care">DHSC</abbr> (to be performed locally)</td>
    </tr>
    <tr>
      <td>99</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Processing through alternative routes</td>
    </tr>
    <tr>
      <td>100</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product is very early stage and concerns over the   amount of equipment required</td>
    </tr>
    <tr>
      <td>101</td>
      <td>Point of care test</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>103</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>105</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not provide additional capacity to   meet <abbr title="Department of Health and Social Care">DHSC</abbr>’s current needs</td>
    </tr>
    <tr>
      <td>106</td>
      <td>Point of care test</td>
      <td>Lateral flow</td>
      <td>Supplier non-engagement, difficulty in obtaining   technical data</td>
    </tr>
    <tr>
      <td>108</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Product is at very early stage and requires CE mark</td>
    </tr>
    <tr>
      <td>112</td>
      <td>Laboratory</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Concerns over extensive manual   pipetting requirement being prone to error and inconsistencies between   sensitivity and specificity</td>
    </tr>
    <tr>
      <td>114</td>
      <td>Laboratory</td>
      <td><abbr title="loop-mediated isothermal amplification">LAMP</abbr></td>
      <td>Assay does not meet <abbr title="target product profile">TPP</abbr> standards for   performance. Biosafety concerns also noted</td>
    </tr>
    <tr>
      <td>121</td>
      <td>Laboratory</td>
      <td>Mass spectrometry</td>
      <td>No-go because of product irregularities (turnaround   time, too complex, high error probability and associated costs)</td>
    </tr>
    <tr>
      <td>123</td>
      <td>Laboratory</td>
      <td>Mass spectrometry</td>
      <td>Assay does not meet <abbr title="target product profile">TPP</abbr> standards for performance</td>
    </tr>
    <tr>
      <td>125</td>
      <td>Laboratory</td>
      <td><abbr title="polymerase chain reaction">PCR</abbr></td>
      <td>Assay does not meet <abbr title="target product profile">TPP</abbr> standards for performance</td>
    </tr>
  </tbody>
</table>

</div>


</div>
</div>
  </div>

  <div data-sticky-element="" class="sticky-element">
    <a class="govuk-link app-c-back-to-top dont-print" href="#contents">
    <svg viewBox="0 0 13 17" width="13" focusable="false" xmlns="http://www.w3.org/2000/svg" height="17" class="app-c-back-to-top__icon">
      <path d="M6.5 0L0 6.5 1.4 8l4-4v12.7h2V4l4.3 4L13 6.4z" fill="currentColor"></path>
    </svg>
    Contents
</a>

    <div class="sticky-element__print-link">
      
<div class="gem-c-print-link govuk-!-display-none-print govuk-!-margin-top-0 govuk-!-margin-bottom-6">
    <button data-module="print-link" class="govuk-link govuk-body-s gem-c-print-link__button">Print this page</button>
</div>
    </div>
  </div>
</div>

    </main>